Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1533 Articles

Chris Lange | Mar 11, 2020 at 9:44 AM EDT

Short Sellers Run for Cover From Big Pharma Stocks

The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical…

Trey Thoelcke | Mar 11, 2020 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Exxon above all other Dow stocks.

Jon C. Ogg | Feb 27, 2020 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Cree, Etsy, Gilead Sciences, Pfizer, Rite Aid, Solar Edge, Square,…

Chris Lange | Feb 27, 2020 at 8:45 AM EST

Big Pharma Scares Off Short Sellers

The February 14 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Feb 27, 2020 at 7:00 AM EST

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Microsoft and Intel above all other Dow stocks.

Chris Lange | Feb 12, 2020 at 9:50 AM EST

Big Pharma Sees a Rising Tide in Short Interest

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Feb 12, 2020 at 6:55 AM EST

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Microsoft and Intel above all other Dow stocks.

Jon C. Ogg | Feb 6, 2020 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive,…

Jon C. Ogg | Feb 5, 2020 at 1:20 PM EST

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

Merck finds itself in a position of being an acquirer of sorts at the same time it wants to spin…

Chris Lange | Jan 28, 2020 at 10:40 AM EST

How Far Will Pfizer Stock Slump?

Pfizer stock retreated after it released a disappointing fourth-quarter earnings report before the opening bell Tuesday.

Chris Lange | Jan 28, 2020 at 9:35 AM EST

Short Sellers Can’t Make Up Their Mind on Big Pharma

The January 15 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Jan 28, 2020 at 7:05 AM EST

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Pfizer and Intel above all other Dow stocks.

Chris Lange | Jan 27, 2020 at 11:30 AM EST

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

These three health care companies included are expected to report their earnings on Tuesday morning.

Chris Lange | Jan 26, 2020 at 7:05 AM EST

Half the Dow Reports This Week: Apple, Exxon, Pfizer and More

24/7 Wall St. has put together a preview of those Dow Jones industrials scheduled to report their quarterly results this…

Chris Lange | Jan 13, 2020 at 9:40 AM EST

Short Sellers Shy Away From Big Pharma

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 26 27 28 29 30 … 103

Pfizer : PFE

All Pfizer Articles

Short Sellers Run for Cover From Big Pharma Stocks

The 5 Most Shorted Dow Stocks

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More

Big Pharma Scares Off Short Sellers

The 5 Most Shorted Dow Stocks

Big Pharma Sees a Rising Tide in Short Interest

The 5 Most Shorted Dow Stocks

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

How Far Will Pfizer Stock Slump?

Short Sellers Can’t Make Up Their Mind on Big Pharma

The 5 Most Shorted Dow Stocks

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

Half the Dow Reports This Week: Apple, Exxon, Pfizer and More

Short Sellers Shy Away From Big Pharma

He Camped One Weekend on Riverfront Land Inside His IRA. Medicare Charged Him for It Two Years Later.

PennantPark vs. PennantPark Floating Rate: Which BDC Pays Income Investors Better?

How to Build $11,800 a Month in Dividend Income Without Selling a Single Share

He Camped One Weekend on Riverfront Land Inside His IRA. Medicare Charged Him for It Two Years Later.

How to Build $11,800 a Month in Dividend Income Without Selling a Single Share

He Camped One Weekend on Riverfront Land Inside His IRA. Medicare Charged Him for It Two Years Later.

PennantPark vs. PennantPark Floating Rate: Which BDC Pays Income Investors Better?

Pfizer : PFE

All Pfizer Articles

Short Sellers Run for Cover From Big Pharma Stocks

The 5 Most Shorted Dow Stocks

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More

Big Pharma Scares Off Short Sellers

The 5 Most Shorted Dow Stocks

Big Pharma Sees a Rising Tide in Short Interest

The 5 Most Shorted Dow Stocks

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

How Far Will Pfizer Stock Slump?

Short Sellers Can’t Make Up Their Mind on Big Pharma

The 5 Most Shorted Dow Stocks

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

Half the Dow Reports This Week: Apple, Exxon, Pfizer and More

Short Sellers Shy Away From Big Pharma

He Camped One Weekend on Riverfront Land Inside His IRA. Medicare Charged Him for It Two Years Later.

PennantPark vs. PennantPark Floating Rate: Which BDC Pays Income Investors Better?

How to Build $11,800 a Month in Dividend Income Without Selling a Single Share

Featured Reads

He Camped One Weekend on Riverfront Land Inside His IRA. Medicare Charged Him for It Two Years Later.

How to Build $11,800 a Month in Dividend Income Without Selling a Single Share